United States - English - NLM (National Library of Medicine)

rebel distributors corp - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v potassium 125 mg in 5 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of penicillin v potassium tablets, penicillin v potassium for oral solution, and other antibacterial drugs, penicillin v potassium tablets and penicillin v potassium for oral solution should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. penicillin v potassium tablets and penicillin v potassium for oral solution are indicated in the treatment of mild to moderately severe infections due to penicillin g-sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericarditis, meningi

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v 125 mg in 5 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of penicillin v potassium tablets, penicillin v potassium for oral solution, and other antibacterial drugs, penicillin v potassium tablets and penicillin v potassium for oral solution should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. penicillin v potassium tablets and penicillin v potassium for oral solution are indicated in the treatment of mild to moderately severe infections due to penicillin g-sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericarditis, meningi

United States - English - NLM (National Library of Medicine)

liberty pharmaceuticals, inc. - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of penicillin v potassium tablets, penicillin v potassium for oral solution and other antibacterial drugs, penicillin v potassium tablets, and penicillin v potassium for oral solution should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antimicrobial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. penicillin v potassium tablets, usp and penicillin v potassium for oral solution, usp, are indicated in the treatment of mild to moderately severe infections due to penicillin g sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericardit

United States - English - NLM (National Library of Medicine)

durvet - penicillin g procaine (unii: 17r794esyn) (penicillin g - unii:q42t66vg0c) - penicillin g 300000 [usp'u] in 1 ml - indications : penicillin g procaine is indicated for the treatment of: 1. cattle and sheep - bacterial pneumonia (shipping fever) caused by pasteurella multocida . 2. swine - erysipelas caused by erysipelothrix rhusiopathiae . 3. horses - strangles caused by streptococcus equi .

United States - English - NLM (National Library of Medicine)

sandoz inc - penicillin g potassium (unii: vl775zth4c) (penicillin g - unii:q42t66vg0c) - penicillin g 5000000 [iu] - buffered penicillin g potassium for injection is indicated in the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below. appropriate culture and susceptibility tests should be done before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to penicillin g. therapy with buffered penicillin g potassium for injection may be initiated before results of such tests are known when there is reason to believe the infection may involve any of the organisms listed below, however, once these results become available, appropriate therapy should be continued. septicemia, empyema, pneumonia, pericarditis, endocarditis, meningitis streptococcus pyogenes (group a beta-hemolytic streptococcus ), other beta-hemolytic streptococci including groups c, h, g, l and m, streptococcus pneumoniae and staphylococcus species (non-penicillinase producing strains) anthrax bacillus anthracis actinomycosis (cer

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - phenoxymethylpenicillin potassium, quantity: 56.568 mg/ml (equivalent: phenoxymethylpenicillin, qty 50 mg/ml) - oral liquid, powder for - excipient ingredients: sucrose; sodium benzoate; saccharin sodium; flavour; colour - when oral therapy is required in the treatment of mild to moderately severe infections due to penicillin sensitive organisms such as penicillin sensitive staphylococci, pneumococci, gonococci and haemolytic streptococci. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recurrent streptococcal infections including the prevention of recurrence following rheumatic fever and/or sydenham's chorea. for the prevention of bacterial endocarditis in patients with rheumatic fever and/or congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation. oral penicillin should not be used as adjunctive prophylaxis for genitourinary instrumentation or surgery, lower intestinal tract surgery, sigmoidoscopy or complications of childbirth.

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - phenoxymethylpenicillin potassium, quantity: 28.284 mg/ml (equivalent: phenoxymethylpenicillin, qty 25 mg/ml) - oral liquid, powder for - excipient ingredients: sucrose; sodium benzoate; saccharin sodium; colour; flavour - when oral therapy is required in the treatment of mild to moderately severe infections due to penicillin sensitive organisms such as penicillin sensitive staphylococci, pneumococci, gonococci and haemolytic streptococci. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recurrent streptococcal infections including the prevention of recurrence following rheumatic fever and/or sydenham's chorea. for the prevention of bacterial endocarditis in patients with rheumatic fever and/or congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation. oral penicillin should not be used as adjunctive prophylaxis for genitourinary instrumentation or surgery, lower intestinal tract surgery, sigmoidoscopy or complications of childbirth.

United States - English - NLM (National Library of Medicine)

durvet - penicillin g procaine (unii: 17r794esyn) (penicillin g - unii:q42t66vg0c) - penicillin g procaine 300000 [usp'u] in 1 ml - penicillin injectable is indicated for treatment of bacterial pneumonia (shipping fever) caused by pasteurella multocida in cattle and sheep, erysipelas caused by erysipelothrix rhusiopathiae in swine, and strangles caused by streptococcus equi in horses.

United States - English - NLM (National Library of Medicine)

a-s medication solutions - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v 250 mg in 5 ml - penicillin v potassium tablets and penicillin v potassium for oral solution are indicated in the treatment of mild to moderately severe infections due to penicillin g-sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericarditis, meningitis, and arthritis should not be treated with penicillin v during the acute stage. indicated surgical procedures should be performed. the following infections will usually respond to adequate dosage of penicillin v. streptococcal infections (without bacteremia). mild-to-moderate infections of the upper respiratory tract, scarlet fever, and mild erysipelas. note: streptococci in groups a, c, g, h, l, and m are very sensitive to penicillin. other groups, including group d (enterococcus), are resistant. pneumococcal infections. mild to moderately severe infections of the respiratory tract. staphylococcal infections —penicillin g-sensitive. mild infec

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - phenoxymethylpenicillin potassium 28.284 mg/ml equivalent to 25 mg/ml phenoxymethylpenicillin.;  ;   - granules for oral solution - 125 mg/5ml - active: phenoxymethylpenicillin potassium 28.284 mg/ml equivalent to 25 mg/ml phenoxymethylpenicillin.     excipient: orange 175-78-8 orange flavour j1978 10814413 saccharin sodium sodium benzoate sucrose as caster sugar. - treatment of mild to moderately severe infections caused by penicillin-sensitive organisms. the following infections will usually respond to an adequate dosage of penicillin.